High-Dose Wegovy Takes Aim at Lilly’s Zepbound
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) said its high-dose version of Wegovy has received a…
Hair-loss drug boosts hair growth by 539% – Irish study
After decades of limited options for male-pattern baldness, a new topical drug has delivered encouraging results in late-stage…